Cite
Weynants P, Humblet Y, Bosly A, et al. Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC). Med Oncol Tumor Pharmacother. 1990;7(4):219-22doi: 10.1007/BF02987098.
Weynants, P., Humblet, Y., Bosly, A., Schallier, D., Duprez, P., Majois, F., Beauduin, M., Prignot, J., & Symann, M. (1990). Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC). Medical oncology and tumor pharmacotherapy, 7(4), 219-22. https://doi.org/10.1007/BF02987098
Weynants, P, et al. "Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)." Medical oncology and tumor pharmacotherapy vol. 7,4 (1990): 219-22. doi: https://doi.org/10.1007/BF02987098
Weynants P, Humblet Y, Bosly A, Schallier D, Duprez P, Majois F, Beauduin M, Prignot J, Symann M. Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC). Med Oncol Tumor Pharmacother. 1990;7(4):219-22. doi: 10.1007/BF02987098. PMID: 2178205.
Copy
Download .nbib